Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cancers|July 29, 2023
Non-Covalent Bruton's Tyrosine Kinase Inhibitors in the Treatment of Chronic Lymphocytic LeukemiaSkye Montoya, Meghan C ThompsonGenes|December 23, 2023
Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL)Alexandra Chirino, Skye Montoya, Anita Safronenka, et al.Trends in Pharmacological Sciences|July 18, 2024
BTK inhibitors: past, present, and futureAllison Cool, Tiffany Nong, Skye Montoya, et al.Biomedicines|November 27, 2021
Targeted Therapies in Cancer: To Be or Not to Be, SelectiveSkye Montoya, Deborah Soong, Nina Nguyen, et al.Leukemia Research|January 25, 2023
Therapy-selected clonal hematopoiesis and its role in myeloid neoplasmsJacob Jahn, Benjamin Diamond, Jeffrey Hsu, et al.Journal of Cellular and Molecular Medicine|February 1, 2023
Protein biomarkers for response to XPO1 inhibition in haematologic malignanciesTulasigeri M Totiger, Sana Chaudhry, Elgilda Musi, et al.Nature Reviews. Clinical Oncology|November 2, 2024
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemiaMichele D Stanchina, Skye Montoya, Alexey V Danilov, et al.Blood|August 5, 2022
Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapyShivani Handa, Jeong-Ok Lee, Andriy Derkach, et al.NPJ Precision Oncology|October 19, 2022
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)Nina Nguyen, Sana Chaudhry, Tulasigeri M Totiger, et al.Leukemia|July 12, 2024
Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibitionSana Chaudhry, Felipe Beckedorff, Shaista Shabbir Jasdanwala, et al.Pageof 2